microTNE (n=169) | TEE (n=167) | P value | |
Patients with adverse events during follow-up, n (%) | 38 (22.5) | 42 (25.1) | 0.61 |
Anaesthesia-related complications | 0 (0.0) | 2 (1.2) | 0.25 |
Atrial fibrillation during closure | 2 (1.2) | 2 (1.2) | 1.0 |
Atrial fibrillation during follow-up | 7 (4.1) | 4 (2.4) | 0.54 |
RBBB | 1 (0.6) | 0 (0.0) | 1.0 |
First-degree atrioventricular block | 1 (0.6) | 0 (0.0) | 1.0 |
Closure device embolisation | 1 (0.6) | 0 (0.0) | 1.0 |
Access site complication | 5 (3.0) | 12 (7.2) | 0.09 |
Nasal complication | 10 (5.9) | 0 (0.0) | 0.002 |
Presyncope or syncope | 8 (4.7) | 5 (3.0) | 0.57 |
Chest pain or dyspnoea | 7 (4.1) | 9 (5.4) | 0.62 |
Migraine worsening | 1 (0.6) | 12 (7.2) | 0.001 |
Stroke | 0 (0.0) | 0 (0.0) | NA |
Transient ischaemic attack | 1 (0.6) | 0 (0.0) | 1.0 |
Deceased | 0 (0.0) | 1 (0.6) | 0.50 |
Variables presented as frequency and percentage.
MicroTNE, transnasal echocardiography with microprobe; PFO, patent foramen ovale; RBBB, right bundle branch block; TEE, transoesophageal echocardiography.